Suppr超能文献

用于重症疟疾患儿低血糖症的舌下含服糖:一项初步临床研究。

Sublingual sugar for hypoglycaemia in children with severe malaria: a pilot clinical study.

作者信息

Graz Bertrand, Dicko Moussa, Willcox Merlin L, Lambert Bernard, Falquet Jacques, Forster Mathieu, Giani Sergio, Diakite Chiaka, Dembele Eugène M, Diallo Drissa, Barennes Hubert

机构信息

Antenna Technologies, Genève, Switzerland.

出版信息

Malar J. 2008 Nov 23;7:242. doi: 10.1186/1475-2875-7-242.

Abstract

BACKGROUND

Hypoglycaemia is a poor prognostic indicator in severe malaria. Intravenous infusions are rarely feasible in rural areas. The efficacy of sublingual sugar (SLS) was assessed in a pilot randomized controlled trial among hypoglycaemic children with severe malaria in Mali.

METHODS

Of 151 patients with presumed severe malaria, 23 children with blood glucose concentrations < 60 mg/dl (< 3.3 mmol/l) were assigned randomly to receive either intravenous 10% glucose (IVG; n = 9) or sublingual sugar (SLS; n = 14). In SLS, a teaspoon of sugar, moistened with a few drops of water, was gently placed under the tongue every 20 minutes. The child was put in the recovery position. Blood glucose concentration (BGC) was measured every 5-10 minutes for the first hour. All children were treated for malaria with intramuscular artemether. The primary outcome measure was treatment response, defined as reaching a BGC of >or= 3.3 mmol/l (60 mg/dl) within 40 minutes after admission. Secondary outcome measures were early treatment response at 20 minutes, relapse (early and late), maximal BGC gain (CGmax), and treatment delay.

RESULTS

There was no significant difference between the groups in the primary outcome measure. Treatment response occurred in 71% and 67% for SLS and IVG, respectively. Among the responders, relapses occurred in 30% on SLS at 40 minutes and in 17% on IVG at 20 minutes. There was one fatality in each group. Treatment failures in the SLS group were related to children with clenched teeth or swallowing the sugar, whereas in the IVG group, they were due to unavoidable delays in beginning an infusion (median time 17.5 min (range 3-40).Among SLS, the BGC increase was rapid among the nine patients who really kept the sugar sublingually. All but one increased their BGC by 10 minutes with a mean gain of 44 mg/dl (95%CI: 20.5-63.4).

CONCLUSION

Sublingual sugar appears to be a child-friendly, well-tolerated and effective promising method of raising blood glucose in severely ill children. More frequent repeated doses are needed to prevent relapse. Children should be monitored for early swallowing which leads to delayed absorption, and in this case another dose of sugar should be given. Sublingual sugar could be proposed as an immediate "first aid" measure while awaiting intravenous glucose. In many cases it may avert the need for intravenous glucose.

摘要

背景

低血糖是重症疟疾预后不良的指标。在农村地区很少能进行静脉输注。在马里对患有重症疟疾的低血糖儿童进行的一项初步随机对照试验中评估了舌下含服糖(SLS)的疗效。

方法

在151例疑似重症疟疾患者中,23名血糖浓度<60mg/dl(<3.3mmol/l)的儿童被随机分配接受静脉注射10%葡萄糖(IVG;n = 9)或舌下含服糖(SLS;n = 14)。在SLS组中,一茶匙糖用几滴水滴湿后,每20分钟轻轻置于舌下。让患儿处于恢复体位。在入院后的第一个小时内每5 - 10分钟测量一次血糖浓度(BGC)。所有儿童均接受肌肉注射蒿甲醚治疗疟疾。主要结局指标为治疗反应,定义为入院后40分钟内BGC达到≥3.3mmol/l(60mg/dl)。次要结局指标为20分钟时的早期治疗反应、复发(早期和晚期)、最大BGC升高值(CGmax)以及治疗延迟。

结果

两组在主要结局指标上无显著差异。SLS组和IVG组的治疗反应分别为71%和67%。在有反应者中,SLS组在40分钟时复发率为30%,IVG组在20分钟时复发率为17%。每组均有1例死亡。SLS组的治疗失败与牙关紧闭或吞咽糖的儿童有关,而IVG组的治疗失败是由于开始输注时不可避免的延迟(中位时间17.5分钟(范围3 - 40分钟))。在SLS组中,9名真正将糖含于舌下的患者血糖升高迅速。除1例患者外,所有患者在10分钟时BGC均升高,平均升高44mg/dl(95%CI:20.5 - 63.4)。

结论

舌下含服糖似乎是一种对儿童友好、耐受性良好且有效的有望提高重症患儿血糖的方法。需要更频繁地重复给药以预防复发。应监测儿童是否早期吞咽,这会导致吸收延迟,在这种情况下应再给予一剂糖。舌下含服糖可作为在等待静脉输注葡萄糖时的一种即时“急救”措施。在许多情况下,它可能避免静脉输注葡萄糖的需要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9255/2605470/4b6efc5a22ab/1475-2875-7-242-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验